SPIRONOLACTONE
| Brand name | CAROSPIR |
|---|---|
| Active ingredient | SPIRONOLACTONE |
| Strength | 25MG/5ML |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9757394 | October 2036 | product |
| 11395828 | October 2036 | use U-3402 |
| 10888570 | October 2036 | product |
| 11389461 | October 2036 | product |
| 10660907 | October 2036 | product |
| 10624906 | October 2036 | product |
| 10493083 | October 2036 | product |
| 11491166 | October 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.